10 June 2020

FRIULCHEM (AIM) - "WITH PHARMABBIE ANOTHER STEP FOR INTERNATIONAL GROWTH IN THE VETERINARY SECTOR"

Friulchem ​​purchased 13% of the capital of Pharmabbie last March, an American company specialized in the development of veterinary drugs to be distributed in the US market through FC-CUBE technology. 

Market Insight Pharmabbie